NEW YORK – Pelotonia, a grassroots organization that raises money to accelerate funding for innovative cancer research, today opened the NASDAQ Stock Market as the guest of its major partner Huntington Bank (Nasdaq: HBAN), one of the nation’s largest banks and headquartered in Columbus, Ohio, in a ceremony at the Nasdaq MarketSite in New York’s Times Square.
“We are honored to be at the NASDAQ Stock Market today as guests of one of our great funding partners, Huntington Bank,” said Doug Ulman, Pelotonia President and CEO and three-time cancer survivor. “As members of the Pelotonia community, we are humbled to stand in this financial powerhouse to mark the culmination of our 10th anniversary and celebrate having raised $184 million for cancer research in one short decade. While we’re proud of that accomplishment, we want to remind everyone that cancer doesn’t take a holiday. And with more than 1,600 Americans dying every day from cancer, continued funding of cancer research is critical to saving lives.”
Ulman was joined at the opening bell ceremony by Steve Steinour, Huntington Bancshares Inc. Chairman, President and CEO and Pelotonia board member; Robert Baiocchi, MD, PhD, hematologist and researcher at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James); and 50 members of the Pelotonia community, including riders, virtual riders, volunteers, partners and cancer survivors.
Huntington Bank is one of Pelotonia’s founding funding partners, a philanthropic-minded financial institution that has offered its continual and increasing support from the ride’s inception. Since the first Pelotonia bike ride in 2009, Huntington Bank has had more than 10,000 of its employees participate as riders, with another nearly 5,000 participating as virtual riders and more than 3,200 as volunteers. Collectively, Huntington Bank employees have raised to date nearly $25.7 million for Pelotonia and, in turn, innovative cancer research at the OSUCCC – James.
“What started 10 years ago by a few people focused on curing cancer has turned into a movement that’s led to new drug discoveries and other prevention therapies, which are helping patients across the country and around the world,” said Steinour. “Pelotonia is a movement that is making a huge impact in advancing science and cures for cancer. That’s why we’re honored and humbled to support this important organization.”
“Pelotonia funding has provided critical research grants to chase the high-impact, high-reward research concepts that represent fresh thinking and potential to make a big difference for families affected by this disease,” said Baiocchi, whose lab has received funding for studies to treat and prevent cancer. “This funding has provided essential support allowing us to translate two new drugs from the lab into the clinic. Pelotonia also allows us to provide meaningful research training experiences to undergraduate, medical, graduate and postdoctoral trainees interested in cancer research careers. This is so important in building the next generation of bright minds and keeping them on mission to beat cancer.”
Since its founding in 2008, Pelotonia has grown into a movement that inspires meaningful collective action by mobilizing purpose-driven communities and accelerating funding for innovative cancer research. In its first decade, the Pelotonia community has made some very notable achievements that include:
- Raising and investing more than $184 million for innovative cancer research.
- Supporting the groundbreaking clinical trials of ibrutinib, which is now FDA approved for the treatment of chronic lymphocytic leukemia and mantle cell lymphoma.
- Participation from more than 25,000 unique riders from all 50 states and 21 countries, and more than one million donations from all 50 states and 70 countries.
- Funding the Ohio Colorectal Cancer Prevention Initiative, which is estimated to have saved more than 1,000 years of life among those screened.
Thanks to Pelotonia’s major funding partners, Pelotonia is able to donate 100 percent of every dollar raised by riders, virtual riders and volunteers directly to the OSUCCC – James. Pelotonia dollars support six major areas at the OSUCCC – James, including:
- Intramural Research Program: This program funds Idea Grants, clinical trials and other initiatives proposed by teams of faculty researchers who need to gather early data for promising projects that may lead to larger external grants later. For example, 134 Idea Grants have been funded to date for OSUCCC – James research teams with transformational ideas. These awardees are selected through a peer-review process conducted by both internal and external scientists not competing for grants in the current funding year.
- Fellowship Program: Funding has been awarded to 479 undergraduate, graduate, medical and postdoctoral student fellowships at The Ohio State University through an annual allocation of $2 million in Pelotonia revenue.
- New Recruit Research Support: Funds raised by Pelotonia have helped invest in the labs of newly recruited junior and senior investigators so they can continue their research upon arrival at Ohio State. A total of 121 researchers have been recipients of Pelotonia support to further their crucial work.
- Instruments of Discovery: Pelotonia funds are allocated to help purchase state-of-the-art equipment needed for cutting-edge cancer research.
- Statewide Initiatives: Pelotonia is funding three statewide clinical research studies focused on colorectal, lung and endometrial cancers. These studies are conducted in partnership with hospitals across the state of Ohio.
- Strategic Research Investments: Pelotonia funds support such initiatives as the Drug Development Institute, Digital Pathology and a Total Cancer Care® protocol at the OSUCCC – James.
Founded in 2008, Pelotonia was established with the objective to fund life-saving cancer research. As a centerpiece of its year-round fundraising efforts, Pelotonia hosts a three-day experience that includes a weekend of cycling, entertainment and volunteerism. In ten years, Pelotonia has raised over $184 million for cancer research. Thanks to its generous funding partners—American Electric Power Foundation, Huntington Bank, L Brands Foundation, Peggy and Richard Santulli, Harold C. Schott Foundation, Lilly Oncology, Cardinal Health, Diamond Hill Capital Management and Nationwide – Pelotonia is able to direct 100 percent of every dollar raised by its participants to cancer research at the OSUCCC – James. For more information, visit pelotonia.org.
Huntington Bancshares Incorporated (Nasdaq: HBAN; www.huntington.com) is a regional bank holding company headquartered in Columbus, Ohio, with $106 billion of assets and a network of 970 branches and 1,860 ATMs across eight Midwestern states. Founded in 1866, The Huntington National Bank and its affiliates provide consumer, small business, commercial, treasury management, wealth management, brokerage, trust and insurance services. Huntington also provides auto dealer, equipment finance, national settlement and capital market services that extend beyond its core states. Visit huntington.com for more information.
About the OSUCCC – James
The OSUCCC – James strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 49 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only a few centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs sponsored by the NCI. As the cancer program’s 356-bed adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet® designation, the highest honor an organization can receive for quality patient care and professional nursing practice. At 21 floors and with more than 1.1 million square feet, The James is a transformational facility that fosters collaboration and integration of cancer research and clinical cancer care. For more information, visit cancer.osu.edu.
The MACH 1 Group for Pelotonia
OSUCCC – James